Quantinno Capital Management LP reduced its stake in Teleflex Incorporated (NYSE:TFX – Free Report) by 30.2% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 53,766 shares of the medical technology company’s stock after selling 23,263 shares during the period. Quantinno Capital Management LP’s holdings in Teleflex were worth $6,431,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds also recently made changes to their positions in TFX. Banque Cantonale Vaudoise lifted its holdings in shares of Teleflex by 82.5% during the fourth quarter. Banque Cantonale Vaudoise now owns 250 shares of the medical technology company’s stock valued at $31,000 after purchasing an additional 113 shares in the last quarter. V Square Quantitative Management LLC purchased a new position in Teleflex in the 4th quarter worth about $37,000. UMB Bank n.a. lifted its stake in Teleflex by 57.1% during the 4th quarter. UMB Bank n.a. now owns 311 shares of the medical technology company’s stock valued at $38,000 after acquiring an additional 113 shares during the period. Sound Income Strategies LLC purchased a new stake in shares of Teleflex during the 4th quarter valued at about $45,000. Finally, Kestra Advisory Services LLC bought a new stake in shares of Teleflex in the fourth quarter worth approximately $45,000. Institutional investors own 95.62% of the company’s stock.
Teleflex Price Performance
NYSE TFX opened at $137.18 on Thursday. The company has a 50-day moving average price of $131.41 and a 200-day moving average price of $122.20. Teleflex Incorporated has a 52 week low of $100.18 and a 52 week high of $144.19. The company has a quick ratio of 2.03, a current ratio of 2.55 and a debt-to-equity ratio of 0.82. The firm has a market capitalization of $6.07 billion, a P/E ratio of -6.02, a PEG ratio of 1.04 and a beta of 0.81.
Teleflex Dividend Announcement
The firm also recently declared a quarterly dividend, which was paid on Tuesday, June 30th. Shareholders of record on Monday, May 25th were given a $0.34 dividend. The ex-dividend date was Friday, May 22nd. This represents a $1.36 annualized dividend and a yield of 1.0%. Teleflex’s dividend payout ratio (DPR) is presently -5.96%.
Wall Street Analysts Forecast Growth
Several research firms have recently weighed in on TFX. Piper Sandler raised shares of Teleflex from a “neutral” rating to an “overweight” rating and boosted their price objective for the company from $140.00 to $160.00 in a report on Monday, June 8th. Mizuho raised their target price on shares of Teleflex from $140.00 to $145.00 and gave the stock a “neutral” rating in a report on Wednesday, July 15th. BMO Capital Markets started coverage on shares of Teleflex in a research report on Wednesday, July 8th. They issued an “outperform” rating and a $159.00 target price for the company. Royal Bank Of Canada upgraded shares of Teleflex from a “sector perform” rating to an “outperform” rating and boosted their target price for the company from $135.00 to $155.00 in a research note on Friday, May 8th. Finally, Wells Fargo & Company increased their price target on Teleflex from $130.00 to $138.00 and gave the company an “equal weight” rating in a report on Friday, May 8th. One equities research analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the company has an average rating of “Hold” and a consensus target price of $148.90.
View Our Latest Research Report on TFX
Teleflex Profile
Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.
The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.
Read More
- Five stocks we like better than Teleflex
- SpaceX: Love the Company, But the Stock Is a Harder Call
- Ulta’s Growth Is Real, But So Are the Risks
- BWX Technologies Is Turning the AI Power Problem Into a Nuclear Growth Story
- Meta’s Earnings Drop Shows Wall Street Wants More Than Ad Growth
Want to see what other hedge funds are holding TFX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teleflex Incorporated (NYSE:TFX – Free Report).
Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.
